Irrational use of antibiotics and clinical outcomes in children with pneumonia
Abstract
Background Pneumonia is a major cause of morbidity and mortality in children under five. Antibiotic treatment must be started immediately in children with pneumonia. The irrational use of antibiotics may increase morbidity and mortality in children with pneumonia.
Obejctive To determine the prevalence of the irrational use of antibiotics and clinical outcomes in children with pneumonia.
Methods We conducted a cross-sectional study in children with pneumonia who were admitted to the Pediatric Ward or PICU at Dr. Sardjito Hospital, Yogyakarta, from December 2010 to February 2013. Data were obtained from subjects’ medical records. Children with malnutrition, congenital heart defects, sepsis, shock, central nervous system disorders, syndromes, or other concomitant infections were excluded.
Results Of 46 children who fulfilled the inclusion criteria, 13 (28.3%) used antibiotics irrationally and 7 (15.2%) died. Most subjects were aged less than 1 year (25 subjects, 54.3%) and 1 - < 5 years (18 subjects, 39.1%). The female to male ratio was 1:1. Most cases were referred from other hospitals (23 subjects, 50%). Twenty-eight (60.9%) subjects stayed in hospital > 7 days. Ampicillin was the most common first-line, empirical antibiotic used (32 subjects, 69.6%). Blood cultures were obtained in 20 (43.5%) patients, yielding no growth in 16 subjects, coagulase-negative staphylococci (CONS) in 3 subjects, and Pseudomonas aeruginosa in 1 subject. The irrational use of antibiotics was significantly associated with mortality in a univariate analysis [PR 6.35; (95%CI 1.40 to 28.69); P=0.006].
Conclusion The irrational use of antibiotics is common among children with pneumonia and is significantly associated with mortality.
References
Latumahina ASN, Triasih R, Hermawan K. Pengembangan dan validasi skor prediksi kematian pada anak dengan pneumonia. [thesis]. [Yogyakarta]: Universitas Gadjah Mada; 2016.
Walker CL, Rudan I, Liu L, Nair H, Theodoratou E, Bhutta ZA, et al. Global burden of childhood pneumonia and diarrhoea. Lancet. 2013;381:1405–16.
Ostapchuk M, Roberts DM, Haddy R. Community-acquired pneumonia in infants and children. Am Fam Physician. 2004;70:899–908.
Ceyhan M, Yildirim I, Ecevit C, Aydogan A, Ornek A, Salman N, et al. Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis. 2010;14:e55–61.
Gerber JS, Newland JG, Coffin SE, Hall M, Thurm C, Prasad PA, et al. Variability in antibiotic use at children’s hospitals. Pediatrics. 2010;126:1067–73.
Marquet K, Liesenborgs A, Bergs J, Vleugels A, Claes N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 2015;19:63.
Murni IK, Duke T, Kinney S, Daley AJ, Soenarto Y. Reducing hospital-acquired infections and improving the rational use of antibiotics in a developing country: an effectiveness study. Arch Dis Child. 2015;100:454-9.
Dorj G, Hendrie D, Parsons R, Sunderland B. An evaluation of prescribing practices for community-acquired pneumonia (CAP) in Mongolia. BMC Health Serv Res. 2013;13:379.
Sachdev HP, Mahajan SC, Garg A. Improving antibiotic and bronchodilator prescription in children presenting with difficult breathing: experience form an urban hospital in India. Indian Pediatr. 2001;38:827-38.
Kementerian Kesehatan. Data dan informasi tahun 2014 (Profil Kesehatan Indonesia), Jakarta: Kementerian Kesehatan Republik Indonesia; 2015.
Setyati A, Murni IK. Pola kuman pasien pneumonia di instalasi rawat intensif anak (IRIA) RSUP Dr. Sardjito. M Med Indones. 2012;46:195-200.
Sectish TC, Charles GP. Pneumonia. In: Behrman RE, editor. Nelson’s textbook of pediatrics. 18th ed. New York: WB Saunders; 2007. p. 1795-9.
Kementerian Kesehatan RI/World Health Organization. Pelayanan kesehatan anak di rumah sakit: Pedoman bagi rumah sakit rujukan tingkat pertama di kabupaten /kota. Jakarta: Kemenkes RI/WHO; 2009. p.86-93.
Widyaningsih R, Buntaran L. Pola kuman penyebab ventilator associated pneumonia (VAP) dan sensitivitas terhadap antibiotik di RSAB Harapan Kita. Sari Pediatri. 2012;13:384-90.
Gyssens IC. Audits for monitoring the quality of antimicrobial prescription. In: Van der Meer JW, Gould IM, editors. Antibiotic policies theory and practice. New York: Kluwer Academic; 2005. p. 197-226.
Watt JP, Wolfson LJ, O’Brien KL, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates. Lancet. 2009;374:903–11.
Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–55.
Adisasmito AW, Hadinegoro SRS. Infeksi gram negatif di ICU anak: epidemiologi, manajemen antibiotik dan pencegahan. Sari Pediatri. 2004;6:32-9.
Athale UH, Brown RC, Furman WL. Immunomodulation. In: Patrick CC, editor. Clinical management of infections in immunocompromized infants and children. 1st ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 584-615.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2017-08-30
Published 2018-01-05
